Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus

Faculty Pharmacy Year: 2022
Type of Publication: ZU Hosted Pages: 1-27
Authors:
Safaa AbdelAal Mohamed AbdelKarim
Journal: PLOS ONE Public Library of Science Volume: 7
Keywords : Promising FDA-approved drugs with efflux pump    
Abstract:
Background and objectives Staphylococcus aureus is an opportunistic pathogen that causes wide range of nosocomial and community-acquired infections which have spread worldwide leading to an urgent need for developing effective antistaphylococcal agents.
    
     
 
       

Author Related Publications

  • Safaa AbdelAal Mohamed AbdelKarim, "Impeding efflux-mediated resistance in Staphylococcus aureus", A & V Publications, 2022 More
  • Safaa AbdelAal Mohamed AbdelKarim, "Antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from urinary tract infections in Zagazig University hospitals", Zagazig J. Pharm. Sci., June, 2016, 2016 More
  • Safaa AbdelAal Mohamed AbdelKarim, "Study on strategies to combat antibiotic resistance in clinical isolates of Staphylococcus aureus", 2024 More

Department Related Publications

  • Mohammed Ali Mohamed Othman, "The Nazi persecution of the Jews and the legal professions, "the civil service laws 1933-1938", جامعة بنها, 2005 More
  • Mohammed Ali Mohamed Othman, "The Nazi policy towards the Jews of German physicians; 1933-1939", جامعةالزقازيق, 2008 More
  • Mohammed Ali Mohamed Othman, "The numbers of German Jews 1871- 1933 the reasons for degradation numerical minority", جامعةالزقازيق, 2006 More
  • Mohammed Ali Mohamed Othman, "The Nazi boycott of Jewish legal profession "March-April" 1933", جامعةالزقازيق, 2007 More
  • Mohammed Ali Mohamed Othman, "The Nazi policy towards the retail trade of Jewish Germans; 1933-1939", جامعةالزقازيق, 2015 More
Tweet